1. RAPT Therapeutics Strengthens Board with Addition of Veteran Biotechnology Executive Wendye Robbins, M.D.

    RAPT Therapeutics Strengthens Board with Addition of Veteran Biotechnology Executive Wendye Robbins, M.D.

    RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company developing oral small molecules for oncology and inflammatory diseases, today announced the addition of Wendye Robbins, M.D., president and CEO of Blade Therapeutics, Inc., to the company’s board of directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned